Ligand validation:9IVN

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 9IVN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IVN_NAD_A_301	94%	50%	0.065	0.964	0.95	0.98	1	4	0	0	100%	1
9IVN_NAD_D_301	94%	55%	0.064	0.961	0.72	1.01	-	4	0	0	100%	1
9IVN_NAD_C_301	93%	54%	0.066	0.96	0.86	0.91	1	2	0	0	100%	1
9IVN_NAD_B_301	92%	44%	0.067	0.958	1.16	1.02	1	2	0	0	100%	1
9IVN_NAD_E_301	92%	47%	0.068	0.959	1.01	1.05	2	4	0	0	100%	1
9IVN_NAD_G_301	90%	50%	0.071	0.954	1.04	0.91	1	3	0	0	100%	1
9IVN_NAD_H_301	89%	55%	0.074	0.952	0.89	0.85	1	4	0	0	100%	1
9IVN_NAD_F_301	77%	57%	0.088	0.925	0.72	0.93	2	1	0	0	100%	1
9IVO_NAD_C_301	76%	42%	0.087	0.921	0.89	1.36	2	10	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
2BJK_NAD_A_1517	100%	59%	0.025	0.995	0.72	0.86	-	1	1	0	100%	0.86
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.